<?xml version="1.0" encoding="UTF-8"?>
<p id="para140">Issues of intellectual property and benefit sharing continue to hamper the development of medical countermeasures during epidemics. Stakeholders need to negotiate intellectual property contracts and agreements to facilitate the sharing of pathogen sequences,
 <xref rid="bib15" ref-type="bibr">
  <sup>15</sup>
 </xref> clinical samples, and diagnostic platforms before outbreaks occur.
 <xref rid="bib16" ref-type="bibr">
  <sup>16</sup>
 </xref> For example, the Pandemic Influenza Preparedness Framework
 <xref rid="bib17" ref-type="bibr">
  <sup>17</sup>
 </xref> was negotiated over 4 years and resulted in a cooperative approach to benefit sharing, as well as substantial cost sharing of the laboratory-based surveillance system. Since its institution, there has been more open sharing of influenza samples. Although the Pandemic Influenza Preparedness Framework is limited by its inability to address sharing of pathogen genetic sequence data, it represents a model on which sample and sequence sharing can be based.
</p>
